Easy One-Step Amplification and Labeling Procedure for Copy Number Variation Detection. Blesa Luján S, Olivares Gazquez M, Alic A, Serrano Alcalá A, Lendinez Tortajada V, Gonzalez Albert V, Olivares Ordoñez L, Martinez Hervas S, Juanes Tébar J, Marin P, Real Collado J, Navarro Cubells B, García García A, Chaves Martínez F, Ivorra C. Clinical Chemistry. 2020 Mar 1;66(3):463-473. doi: 10.1093/clinchem/hvaa002. PMID: 32068788

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. Bakris G, Agarwal R, Anker S, Pitt B, Ruilope L, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G, FIDELIO-DKD Investigators. New England journal of medicine. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. PMID: 33264825

Have the Government’s prescription algorithm and the 2013 American College of Cardiology/American Heart Association guidelines for managing dyslipidaemia influenced the management of dyslipidaemia?. The MEJORALO-CV Project. Giner Galvan V, Bonig Trigueros I, Facila Rubio L, Morillas Blasco P, Martinez Hervas S, Pascual Fuster V, Valls Roca F, Soler Portmann C, Tamarit Garcia J, Pallares Carratala V, Componentes del grupo de Trabajo MEJORALO-CV. Revista Clinica Espanola. 2020;220(5):282-289. doi: 10.1016/j.rce.2019.08.006. PMID: 31744620

Impact of Cholesterol Metabolism in Immune Cell Function and Atherosclerosis. Aguilar Ballester M, Herrero Cervera A, Vinué Visús M, Martinez Hervas S, González Navarro H. Nutrients. 2020 Jul 7;12(7):2021. doi: 10.3390/nu12072021. PMID: 32645995

Postprandial triglyceridemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects. Moreno-Perez B, Benito E, Civera M, Alabadi B, Martinez-Hervas S, Peiro M, Gonzalez-Navarro H, Piqueras L, Jesus Sanz M, Ascaso J, Real J. International Journal of Clinical Practice. 2020 Oct 21;e13776. doi: 10.1111/ijcp.13776. PMID: 33089594

Real-world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon-like peptide-1 receptor agonists. Rosenstock J, Ampudia Blasco FJ, Lubwama R, Peng XV, Boss A, Shi L, Fonseca V. Diabetes Obesity & Metabolism. 2020 Dec;22(12):2295-2304. doi: 10.1111/dom.14154. PMID: 32729183

Srebf2 Locus Overexpression Reduces Body Weight, Total Cholesterol and Glucose Levels in Mice Fed with Two Different Diets. Andres-Blasco I, Blesa S, Vinue A, Gonzalez-Navarro H, Real J, Martinez-Hervas S, Carretero J, Ferrandez-Izquierdo A, Chaves F, Garcia-Garcia A. Nutrients. 2020 Oct 14;12(10):3130. doi: 10.3390/nu12103130. PMID: 33066385

Study of abnormal adrenal receptors in subjects with ACTH-independent Cushing’s syndrome and nodular adrenal hyperplasia. Ferri Ciscar J, Perelló Camacho E, Lorente Calvo R, Argente C, Rossetti P, Pedro T, Martinez Hervas S, Real Collado J. Endocrinologia Diabetes y Nutricion. 2020 Apr;67(4):245-252. doi: 10.1016/j.endinu.2019.07.005. PMID: 31672533

Two clinical cases of adjunctive use of a SGLT-2 inhibitor in type 1 diabetes. Siegmund T, Ampudia Blasco J, Schnell O. Diabetes Research and Clinical Practice. 2020 Apr;162:108131. doi: 10.1016/j.diabres.2020.108131. PMID: 32234505

Update on postprandial hyperglycaemia: the pathophysiology, prevalence, consequences and implications of treating diabetes. Pinés Corrales P, Bellido Castañeda V, Ampudia Blasco J. Revista Clinica Espanola. 2020;220(1):57-68. doi: 10.1016/j.rce.2018.06.015. PMID: 30527933

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors. Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B, Close KL, Dandona P, Dutta S, Ferrannini E, Fourlanos S, Grunberger G, Heller SR, Henry RR, Kurian MJ, Kushner JA, Oron T, Parkin CG, Pieber TR, Rodbard HW, Schatz D, Skyler JS, Tamborlane WV, Yokote K, Phillip M. Diabetes Care. 2019 Jun;42(6):1147-1154. doi: 10.2337/dc18-2316. PMID: 30728224

Novel Immune Features of the Systemic Inflammation Associated with Primary Hypercholesterolemia: Changes in Cytokine/Chemokine Profile, Increased Platelet and Leukocyte Activation. Collado A, Marques P, Domingo E, Perello E, González-Navarro H, Martinez-Hervás S, Real JT, Piqueras L, Ascaso JF, Sanz MJ. Journal of Clinical Medicine. 2019 Jan; 8(1): 18. PMID: 30583563

Respiratory chain polymorphisms and obesity in the Spanish population, a cross-sectional study. de Marco G, Garcia-Garcia AB, Real JT, Gonzalez-Albert V, Briongos-Figuero LS, Cobos-Siles M, Lago-Sampedro A, Corbaton A, Teresa Martinez-Larrad M, Carmena R, Martin-Escudero JC, Rojo-Martínez G, Chaves FJ. BMJ Open. 2019 Feb 19;9(2):e027004. doi: 10.1136/bmjopen-2018-027004. PMID: 30782949

SGLT-2 (Sodium-Glucose Cotransporter 2) Inhibition Reduces Ang II (Anciotensin II)-Induced Dissecting Abdominal Aortic Aneurysm in ApoE (Apolipoprotein E) Knockout Mice. Ortega R, Collado A, Selles F, Gonzalez-Navarro H, Sanz MJ, Real JT, Piqueras L. Arteriosclerosis Thrombosis and Vascular Biology. 2019 Aug;39(8):1614-1628. doi: 10.1161/ATVBAHA.119.312659. PMID: 31294626

Systemic Inflammation in Metabolic Syndrome: Increased Platelet and Leukocyte Activation, and Key Role of CX3CL1/CX3CR1 and CCL2/CCR2 Axes in Arterial Platelet-Proinflammatory Monocyte Adhesion. Marques P, Collado A, Martinez-Hervás S, Domingo E, Benito E, Piqueras L, Real JT, Ascaso JF, Sanz MJ. Journal of Clinical Medicine. 2019 May 18;8(5):708. doi: 10.3390/jcm8050708. PMID: 31109070

Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased CDKN2A/2B/2BAS gene expression in leukocytes. Martínez-Hervás S, Sánchez-García V, Herrero-Cervera A, Vinué Á, Real JT, Ascaso JF, Burks DJ, González-Navarro H. Journal of Translational Medicine. 2019 Jul 12;17(1):222. doi: 10.1186/s12967-019-1977-1. PMID: 31299986